ZNF260
Zinc finger protein 260
Also known as: ozrf1, Zfp260, ZN260_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3ZCT1
- Gene
- ZNF260
- Ensembl
- ENSG00000254004
- Chromosome
- 19
- Canonical length
- 412 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
412 residues, UniProt reviewed canonical sequence.
>Q3ZCT1|ZNF260
1 MIGMLESLQH ESDLLQHDQI HTGEKPYECN ECRKTFSLKQ NLVEHKKMHT GEKSHECTEC
61 GKVCSRVSSL TLHLRSHTGK KAYKCNKCGK AFSQKENFLS HQKHHTGEKP YECEKVSIQM
121 PTIIRHQKNH TGTKPYACKE CGKAFNGKAY LTEHEKIHTG EKPFECNQCG RAFSQKQYLI
181 KHQNIHTGKK PFKCSECGKA FSQKENLIIH QRIHTGEKPY ECKGCGKAFI QKSSLIRHQR
241 SHTGEKPYTC KECGKAFSGK SNLTEHEKIH IGEKPYKCNE CGTIFRQKQY LIKHHNIHTG
301 EKPYECNKCG KAFSRITSLI VHVRIHTGDK PYECKVCGKA FCQSSSLTVH MRSHTGEKPY
361 GCNECGKAFS QFSTLALHMR IHTGEKPYQC SECGKAFSQK SHHIRHQRIH THLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF260 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 11 nTPM
- thyroid gland: 9.1 nTPM
- ovary: 8.5 nTPM
- retina: 8.2 nTPM
- breast: 7.4 nTPM
- thymus: 7.1 nTPM
Single-cell type
- tuft cells: 46 nCPM
- suprabasal keratinocytes: 45 nCPM
- urothelial cells: 36 nCPM
- esophageal apical cells: 36 nCPM
- breast secretory cells: 34 nCPM
- breast hormone-responsive cells: 34 nCPM
Immune cell
- basophil: 4.5 nTPM
- naive CD4 T-cell: 3.1 nTPM
- naive B-cell: 2.9 nTPM
- memory B-cell: 2.4 nTPM
- naive CD8 T-cell: 2.4 nTPM
- memory CD4 T-cell: 2.3 nTPM
Brain region
- white matter: 14 nTPM
- thalamus: 12 nTPM
- hypothalamus: 12 nTPM
- midbrain: 12 nTPM
- basal ganglia: 12 nTPM
- cerebellum: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.23
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.61
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF260 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF260 as an antibody target. Whether an autoantibody or antibody against ZNF260 could matter depends on whether native ZNF260 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF260 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF260 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...